Nasdaq · CIK 0000012239
DOMH Dominari Holdings Inc.
Insider trading from SEC Form 4. Last filing 29 d ago. Close $2.17 on Oct 9, 2026, +12% from the 52-week low and -59% from the high.
Dominari Holdings Inc. (DOMH) has 35 SEC Form 4 filings on file from 10 insiders, the latest filed on Sep 14, 2026. In the last 90 days insiders made 2 open-market buys worth $418k and 0 open-market sells worth $0, net +$418k.
8 open-market trades have been scored at DOMH. The newest: Kyle Michael Wool (President) bought $209k of stock on Sep 10, 2026, filed Sep 14, 2026, scored 40 (moderate). The largest of the 8 shown: Christopher Franklin Devall (COO) sold $871k on Dec 3, 2025, scored 63 (notable). 2 insiders bought within 14 days of each other around Sep 10, 2026.
DOMH closed at $2.17 on Oct 9, 2026, 12% above its 52-week low and 59% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Dominari Holdings Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Kyle Michael Wool President buy | $209k 100,000 shares | +2% | - | |
| 45Moderate | Anthony Hayes CEO buy | $209k 100,000 shares | +2% | - | |
| 36Weak | Christopher Franklin Devall COO sell | $173k 45,000 shares | -24% | +360% from low-68% from high | |
| 50Moderate | Anthony Hayes CEO buy | $89k 23,000 shares | +1% | +360% from low-68% from high | |
| 46Moderate | Kyle Michael Wool President buy | $97k 25,000 shares | +1% | +360% from low-68% from high | |
| 46Moderate | Kyle Michael Wool President buy | $97k 25,000 shares | +2% | +360% from low-68% from high | |
| 50Moderate | Anthony Hayes CEO buy | $89k 23,000 shares | +1% | +360% from low-68% from high | |
| 63Notable | Christopher Franklin Devall COO sell | $871k 220,000 shares | -54% | +414% from low-64% from high |
Transactions
The newest 50 of 61 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Kyle Michael Wool President | POpen-market purchase Common Stock | +50,000 | $2.02 | $101k | 4,261,828 | 29 d ago |
| Sep 10, 2026 | Anthony Hayes CEO | POpen-market purchase Common Stock | +50,000 | $2.02 | $101k | 4,550,873 | 29 d ago |
| Sep 11, 2026 | Kyle Michael Wool President | POpen-market purchase Common Stock | +50,000 | $2.16 | $108k | 4,311,828 | 29 d ago |
| Sep 11, 2026 | Anthony Hayes CEO | POpen-market purchase Common Stock | +50,000 | $2.16 | $108k | 4,600,873 | 29 d ago |
| Jan 9, 2026 | Tim S Ledwick Chief Financial Officer | AGrant or award Common Stock | +316,346 | - | - | 347,817 | Mar 25, 2026 |
| Jan 9, 2026 | Gregory James Blattner director | AGrant or award Common Stock | +25,000 | - | - | 47,411 | Mar 24, 2026 |
| Mar 4, 2026 | Anthony Hayes CEO | AGrant or award Common Stock | +3,000,000 | - | - | 4,750,873 | Mar 24, 2026 |
| Jan 9, 2026 | Kyle Haug director | AGrant or award Common Stock | +25,000 | - | - | 49,409 | Mar 24, 2026 |
| Jan 9, 2026 | Brian Keith Parsley director | AGrant or award Common Stock | +25,000 | - | - | 25,000 | Mar 24, 2026 |
| Mar 4, 2026 | Kyle Michael Wool President | AGrant or award Common Stock | +3,000,000 | - | - | 4,211,828 | Mar 24, 2026 |
| Dec 11, 2025 | Christopher Franklin Devall COO | AGrant or award Common Stock | +10,000 | - | - | 155,702 | Dec 12, 2025 |
| Dec 8, 2025 | Anthony Hayes CEO | POpen-market purchase Common Stock | +23,000 | $3.87 | $89k | 1,750,873 | Dec 10, 2025 |
| Dec 8, 2025 | Christopher Franklin Devall COO | SOpen-market sale Common Stock | -45,000 | $3.85 | $173k | 145,702 | Dec 10, 2025 |
| Dec 8, 2025 | Anthony Hayes CEO | POpen-market purchase Common Stock | -23,000 | $3.87 | $89k | 1,750,873 | Dec 10, 2025 |
| Dec 8, 2025 | Kyle Michael Wool President | POpen-market purchase Common Stock | -25,000 | $3.87 | $97k | 2,453,817 | Dec 10, 2025 |
| Dec 8, 2025 | Kyle Michael Wool President | POpen-market purchase Common Stock | +25,000 | $3.87 | $97k | 1,211,828 | Dec 10, 2025 |
| Dec 3, 2025 | Christopher Franklin Devall COO | SOpen-market sale Common Stock | -40,000 | $4.22 | $169k | 370,702 | Dec 5, 2025 |
| Dec 4, 2025 | Christopher Franklin Devall COO | SOpen-market sale Common Stock | -40,000 | $4.21 | $169k | 330,702 | Dec 5, 2025 |
| Dec 5, 2025 | Christopher Franklin Devall COO | SOpen-market sale Common Stock | -140,000 | $3.82 | $534k | 190,702 | Dec 5, 2025 |
| Feb 10, 2025 | Ronald Craig Lieberman director | POpen-market purchase Common Stock | +21,613 | - | - | 21,613 | Sep 30, 2025 |
| Feb 18, 2025 | Ronald Craig Lieberman director | AGrant or award Common Stock | +150,000 | - | - | 181,613 | Sep 30, 2025 |
| Feb 10, 2025 | Ronald Craig Lieberman director | AGrant or award Common Stock | +10,000 | - | - | 31,613 | Sep 30, 2025 |
| Feb 10, 2025 | Ronald Craig Lieberman director | POpen-market purchase Series A Warrants (right to buy)derivative | +21,613 | - | - | 21,613 | Sep 30, 2025 |
| Feb 10, 2025 | Ronald Craig Lieberman director | POpen-market purchase Series B Warrants (right to buy)derivative | +21,613 | - | - | 21,613 | Sep 30, 2025 |
| Sep 23, 2025 | Gregory James Blattner director | SOpen-market sale Common Stock | -14,409 | - | - | 22,411 | Sep 25, 2025 |
| May 5, 2025 | Anthony Hayes CEO | GGift Common Stock | -15,000 | - | - | 1,614,566 | May 6, 2025 |
| Apr 16, 2025 | Anthony Hayes CEO | AGrant or award Stock Option (right to buy)derivative | +5,000,000 | - | - | 5,000,000 | Apr 16, 2025 |
| Apr 16, 2025 | Kyle Michael Wool President | AGrant or award Stock Option (right to buy)derivative | +5,000,000 | - | - | 5,000,000 | Apr 16, 2025 |
| Mar 24, 2025 | Anthony Hayes CEO | AGrant or award Common Stock | +154,559 | - | - | 1,629,566 | Mar 25, 2025 |
| Feb 12, 2025 | Kyle Michael Wool President | AGrant or award Common Stock | +154,559 | - | - | 2,355,328 | Mar 25, 2025 |
| Feb 18, 2025 | Ronald J. Lieberman director | AGrant or award Common Stock | +150,000 | - | - | 181,613 | Feb 20, 2025 |
| Feb 18, 2025 | Anthony Hayes CEO | AGrant or award Common Stock | +500,000 | - | - | 1,475,007 | Feb 20, 2025 |
| Feb 10, 2025 | Tim S Ledwick Chief Financial Officer | POpen-market purchase Common Stock | +8,645 | - | - | 21,471 | Feb 12, 2025 |
| Feb 10, 2025 | Christopher Franklin Devall COO | POpen-market purchase Common Stock | +28,818 | - | - | 58,851 | Feb 12, 2025 |
| Feb 10, 2025 | Robert Frederick Dudley director | AGrant or award Common Stock | +10,000 | - | - | 22,411 | Feb 12, 2025 |
| Feb 10, 2025 | Anthony Hayes CEO | POpen-market purchase Common Stock | +288,184 | - | - | 975,007 | Feb 12, 2025 |
| Feb 10, 2025 | Kyle Haug director | POpen-market purchase Common Stock | +14,409 | - | - | 14,409 | Feb 12, 2025 |
| Feb 10, 2025 | Ronald J. Lieberman director | POpen-market purchase Common Stock | +21,613 | - | - | 21,613 | Feb 12, 2025 |
| Feb 12, 2025 | Kyle Michael Wool President | POpen-market purchase Common Stock | +288,184 | - | - | 2,200,769 | Feb 12, 2025 |
| Feb 10, 2025 | Gregory James Blattner director | POpen-market purchase Common Stock | +14,409 | - | - | 26,820 | Feb 12, 2025 |
| Feb 10, 2025 | Christopher Franklin Devall COO | AGrant or award Common Stock | +351,851 | - | - | 410,702 | Feb 12, 2025 |
| Feb 10, 2025 | Kyle Haug director | AGrant or award Common Stock | +10,000 | - | - | 24,409 | Feb 12, 2025 |
| Feb 10, 2025 | Tim S Ledwick Chief Financial Officer | AGrant or award Common Stock | +10,000 | - | - | 31,471 | Feb 12, 2025 |
| Feb 10, 2025 | Ronald J. Lieberman director | AGrant or award Common Stock | +10,000 | - | - | 31,613 | Feb 12, 2025 |
| Feb 10, 2025 | Gregory James Blattner director | AGrant or award Common Stock | +10,000 | - | - | 36,820 | Feb 12, 2025 |
| Feb 10, 2025 | Gregory James Blattner director | POpen-market purchase Series A Warrants (right to buy)derivative | +14,409 | - | - | 14,409 | Feb 12, 2025 |
| Feb 10, 2025 | Christopher Franklin Devall COO | POpen-market purchase Series A Warrants (right to buy)derivative | +28,818 | - | - | 28,818 | Feb 12, 2025 |
| Feb 10, 2025 | Anthony Hayes CEO | POpen-market purchase Series A Warrants (right to buy)derivative | +288,184 | - | - | 288,184 | Feb 12, 2025 |
| Feb 10, 2025 | Kyle Haug director | POpen-market purchase Series A Warrants (right to buy)derivative | +14,409 | - | - | 14,409 | Feb 12, 2025 |
| Feb 10, 2025 | Tim S Ledwick Chief Financial Officer | POpen-market purchase Series A Warrants (right to buy)derivative | +8,645 | - | - | 8,645 | Feb 12, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Gregory James Blattnerdirector
- Christopher Franklin DevallCOO
- Robert Frederick Dudleydirector
- Kyle Haugdirector
- Anthony HayesCEO
- Tim S LedwickChief Financial Officer
- Ronald Craig Liebermandirector
- Ronald J. Liebermandirector
- Brian Keith Parsleydirector
- Kyle Michael WoolPresident
Questions about DOMH
Answered from the filings on this page, as of the latest one.
Are insiders buying DOMH?
As of Sep 14, 2026, SEC Form 4 filings show 2 open-market buys worth $418k by 2 insiders and 0 open-market sells worth $0 by 0 insiders at Dominari Holdings Inc. in the last 90 days, net +$418k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade DOMH on the open market?
Kyle Michael Wool (President) bought $209k of DOMH on Sep 10, 2026 and filed the Form 4 on Sep 14, 2026. InsiderTell scored 40 (moderate), with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at Dominari Holdings Inc.?
10 people have filed a Form 4 at Dominari Holdings Inc., among them Gregory James Blattner (director), Christopher Franklin Devall (COO), Robert Frederick Dudley (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.